Signal for Thrombosis with Eltrombopag and Romiplostim: A Disproportionality Analysis of Spontaneous Reports Within VigiBase ®
Conclusion
This study suggests the presence of a signal for an increased risk of thrombosis with eltrombopag compared with romiplostim. These results must be confirmed and quantified by large aetiological pharmacoepidemiological studies.
Source: Drug Safety - Category: Drugs & Pharmacology Source Type: research
More News: Databases & Libraries | Drugs & Pharmacology | Health | Heart Attack | International Medicine & Public Health | Ischemic Stroke | Stroke | Study | Thrombocytopenia | Thrombosis | WHO